2cX
Desconocido
DECIDER: Improved clinical decisions via integrating multiple data levels to overcome chemotherapy resistance...
2CUREX AS
participó en un
H2020:
H2020-SC1-BHC-2018-2020
The goals of this inter-disciplinary project are to 1) gain understanding of the mechanisms causing chemoresistance in high-grade serous ova...
2021-01-21 - 2026-07-31 | Financiado
2021-01-21 - 2026-07-31 | Financiado
MicroCaT: Micro tumor Guided Cancer Therapy Selection MicroCaT
2CUREX AS
tramitó un
H2020:
H2020-SMEInst-2016-2017
Every year around 350.000 patients in the EU are newly diagnosed with colorectal cancer (CRC). Although € 1.4 Billion are
spent on CRC drug...
2018-01-20 - 2021-03-31 | Financiado
2018-01-20 - 2021-03-31 | Financiado
CHEMOGUIDE: Chemotherapy guidance based on efficacy of treatment regimen in cancer cells from the individual pat...
2CUREX AS
tramitó un
FP7:
The ChemoGuide project will clinically validate a proto-type technology (2treat) developed in the previous Research for SMEs project, Integr...
Financiado
Financiado
ICSC: Integrated Chemical synthesis and Screening in patient Cells
2CUREX AS
tramitó un
FP7:
The ICSC project is a Research for SMEs focused research project that is to develop an integrated high throughput chemical synthesis and cel...
Financiado
Financiado
* No se disponen de datos de la empresa actual.